Skip to main content
. 2019 Jun 23;12:100326. doi: 10.1016/j.ebr.2019.100326

Table 2.

Timing of immunotherapy and epilepsy markers.

Case 1 Case 2 Case 3
Time (days) Between IVIg and …
 1st Seizure 7 4 11
 Refractory SE 34 14 1st: 93 2nd: 4
 Ketamine Infusion 43 18 1st: 125 2nd: 36
 Discontinuation of SE 44 19 1st: 127 2nd: 38
Time (days) Between IV methylprednisolone and …
 1st Seizure 7 4 11
 Refractory SE 34 14 93
 Ketamine Infusion 43 18 125
 Discontinuation of SE 44 19 127
Time (days) Between 1st Infusion of Rituximab and
 1st Seizure n/a n/a n/a
 Refractory SE 21 10 n/a
 Ketamine Infusion 30 14 n/a
 Discontinuation of SE 31 15 n/a
Time (days) between CD19/20% at 0 and Ketamine use … 19 7 120